Fresenius Corporate Profile
Financials
2018 Annual Revenue
$16.55 billion
2018 Gross Profit
$5.16 billion
2018 Annual Net Income
$1.98 billion
2018 Fiscal Year Net Income Growth
54.84%
Credit Rating
The lease is guaranteed by Fresenius Medical Care Holdings, Inc., which senior unsecured notes are Investment Grade BBB.
Fresenius Corporate Profile
Fresenius Medical Care (NYSE: FMS) provides dialysis and related products, inpatient/outpatient care products, and services such as engineering to hospitals and related facilities. Fresenius operates more than 2,100 dialysis centers in North America and has over 100,000 employees.